Michelle DuPont
2PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Sep 19, 2023
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance.Mandy Lawson, Natalie Cureton, Susana Ros
Pageof 1
Frequent Collaborators
1 joint publications
Mandy Lawson
1 joint publications
Natalie Cureton
1 joint publications
Susana Ros
1 joint publications
Azadeh Cheraghchi-Bashi
1 joint publications
Jelena Urosevic
1 joint publications
Sophie D'Arcy
1 joint publications
Oona Delpuech
1 joint publications
David I Fisher
1 joint publications
Eric T Gangl
1 joint publications
Hilary Lewis